- On the basis of its move to a direct distribution model, Chembio Diagnostics ((NASDAQ:CEMI) +.4%) terminates its U.S. STAT-PAK distribution agreement with Alere (ALR +1.3%) (formerly Inverness Medical Innovations).
- Alere had the rights since 2006 to sell the firm's STAT-PAK HIV assays in the U.S. under its Clearview brand.
- CEMI is currently in the midst of a sales force build out.